HHLR ADVISORS LTD. 13D/13G Filings for ArriVent BioPharma, Inc. Common Stock (AVBP)

HHLR ADVISORS LTD. 13D and 13G filings for ArriVent BioPharma, Inc. Common Stock:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-14
4:33 pm
Purchase
2024-09-3013GArriVent BioPharma, Inc. Common Stock
AVBP
HHLR ADVISORS LTD.4,484,672
13.400%
4,484,672increase
(New Position)
Filing